# Retraction: Salidroside inhibits the proliferation and migration of gastric carcinoma cells and tumor growth via the activation of ERS-dependent autophagy and apoptosis

**Authors:** Wei Yan, Kai Li, Amin Buhe, Tianxiong Li, Peirong Tian, Jun Hong

PMC · DOI: 10.1039/d4ra90046d · 2024-04-25

## TL;DR

This paper is a retraction of a previous study that claimed salidroside inhibits gastric cancer cell growth through autophagy and apoptosis.

## Contribution

The paper formally retracts a prior claim about salidroside's anti-cancer effects.

## Key findings

- The original study's findings are no longer considered valid.
- The retraction highlights the need for further research on salidroside's effects.

## Abstract

Retraction of ‘Salidroside inhibits the proliferation and migration of gastric carcinoma cells and tumor growth via the activation of ERS-dependent autophagy and apoptosis' by Wei Yan et al., RSC Adv., 2019, 9, 25655–25666, https://doi.org/10.1039/C9RA00044E.

## Linked entities

- **Chemicals:** salidroside (PubChem CID 159278)
- **Diseases:** gastric carcinoma (MONDO:0004950)

## Full-text entities

- **Diseases:** tumor (MESH:D009369), gastric carcinoma (MESH:D013274)
- **Chemicals:** Salidroside (MESH:C009172)

---
Source: https://tomesphere.com/paper/PMC11043916